Institutional stakeholder perceptions of barriers to addiction treatment under Mexico's drug policy reform

dc.contributor.affiliationDepartment of Medicine , University of California San Diego , San Diego , CA , USA
dc.contributor.emaill.beletsky@neu.edu (Leo Beletsky)
dc.creatorWerb, Danes_ES
dc.creatorStrathdee, Steffanie A.es_ES
dc.creatorMeza, Emilioes_ES
dc.creatorRangel Gomez, Maria Gudeliaes_ES
dc.creatorPalinkas, Lawrencees_ES
dc.creatorMedina-Mora, María Elenaes_ES
dc.creatorBeletsky, Leoes_ES
dc.date2017
dc.date.accessioned2025-10-06T19:31:22Z
dc.date.accessioned2026-03-27T15:32:59Z
dc.date.available2025-10-06T19:31:22Z
dc.date.issued2017
dc.date.published2017
dc.descriptionMexico has experienced disproportionate drug-related harms given its role as a production and transit zone for illegal drugs destined primarily for the USA. In response, in 2009, the Mexican federal government passed legislation mandating pre-arrest diversion of drug-dependent individuals towards addiction treatment. However, this federal law was not specific about how the scale-up of the addiction treatment sector was to be operationalised. We therefore conducted in-depth qualitative interviews with key 'interactors' in fields affected by the federal legislation, including participants from the law enforcement, public health, addiction treatment, and governmental administration sectors. Among 19 participants from the municipal, state and federal levels were interviewed and multiple barriers to policy reform were identified. First, there is a lack of institutional expertise to implement the reform. Second, the operationalisation of the reform was not accompanied by a coordinated action plan. Third, the law is an unfunded mandate. Institutional barriers are likely hampering the implementation of Mexico's policy reform. Addressing the concerns expressed by interactors through the scale-up of services, the provision of increased training and education programmes for stakeholders and a coordinated action plan to operationalise the policy reform are likely needed to improve the policy reform process.es_ES
dc.formatPDFes_ES
dc.identifier.doi10.1080/17441692.2015.1093524
dc.identifier.eissn1744-1706
dc.identifier.issn1744-1692
dc.identifier.organizacionInstituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
dc.identifier.placeInglaterra
dc.identifier.urihttps://doi.org/10.1080/17441692.2015.1093524
dc.identifier.urihttps://pmc.ncbi.nlm.nih.gov/articles/PMC5612664/
dc.identifier.urihttps://repositorio.inprf.gob.mx/handle/123456789/8446
dc.language.isoenges_ES
dc.publisherInforma Healthcarees_ES
dc.relation12(5):519-530
dc.relation.jnabreviadoGLOB PUBLIC HEALTH
dc.relation.journalGlobal Public Health
dc.rightsAcceso Cerradoes_ES
dc.subject.kwMexico
dc.subject.kwDrug policy reform
dc.subject.kwAddiction treatment
dc.subject.kwInstitutional barriers
dc.subject.kwTijuana
dc.titleInstitutional stakeholder perceptions of barriers to addiction treatment under Mexico's drug policy reformes_ES
dc.typeArtículoes_ES

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description: